Theolytics
Theolytics is a pre-clinical biotech company harnessing oncolytics viruses to treat cancers, utilising systematic phenotypic screening and selection systems optimised for translational success.
- What
- Life Sciences
- When
- Dec 2017
- CEO
- David Apelian
- Status
- Private
- Investment
- Active